Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 21626278)

Published in MAGMA on May 29, 2011

Authors

Anders Garpebring1, Ronnie Wirestam, Jun Yu, Thomas Asklund, Mikael Karlsson

Author Affiliations

1: Division of Radiation Physics, Department of Radiation Sciences, Umeå University, SE-901 87 Umeå, Sweden. anders.garpebring@radfys.umu.se

Articles cited by this

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol (2005) 5.60

Engineering and algorithm design for an image processing Api: a technical report on ITK--the Insight Toolkit. Stud Health Technol Inform (2002) 4.65

Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med (2006) 3.63

Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys (1997) 3.14

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85

Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev (2009) 2.52

Optimal radiofrequency and gradient spoiling for improved accuracy of T1 and B1 measurements using fast steady-state techniques. Magn Reson Med (2010) 1.72

Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging (1997) 1.69

Measuring the arterial input function with gradient echo sequences. Magn Reson Med (2003) 1.60

Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles. Magn Reson Med (2009) 1.51

In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys (2008) 1.19

Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke (1987) 1.19

Prebolus quantitative MR heart perfusion imaging. Magn Reson Med (2004) 1.17

Quantitative CBV measurement from static T1 changes in tissue and correction for intravascular water exchange. Magn Reson Med (2006) 1.14

The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. Phys Med Biol (2010) 1.14

Partial volume effects on arterial input functions: shape and amplitude distortions and their correction. J Magn Reson Imaging (2005) 1.10

Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med (2001) 1.09

Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging (2008) 1.05

Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J Magn Reson Imaging (2005) 1.04

Contrast-agent phase effects: an experimental system for analysis of susceptibility, concentration, and bolus input function kinetics. Magn Reson Med (1997) 0.88

Phase-based arterial input function measurements for dynamic susceptibility contrast MRI. Magn Reson Med (2010) 0.82

Determination of the venous output function from MR signal phase: feasibility for quantitative DCE-MRI in human brain. Magn Reson Med (2010) 0.82

Arterial input functions from MR phase imaging. Magn Reson Med (1996) 0.82

Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI. J Magn Reson Imaging (2007) 0.81

A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent. Magn Reson Imaging (2005) 0.80

Effects of inflow and radiofrequency spoiling on the arterial input function in dynamic contrast-enhanced MRI: a combined phantom and simulation study. Magn Reson Med (2011) 0.77

MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts. Magn Reson Med (1992) 0.77

Articles by these authors

(truncated to the top 100)

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

International network of cancer genome projects. Nature (2010) 20.35

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Prepublication data sharing. Nature (2009) 12.24

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92

VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res (2005) 4.77

RePS: a sequence assembler that masks exact repeats identified from the shotgun data. Genome Res (2002) 4.35

KaKs_Calculator: calculating Ka and Ks through model selection and model averaging. Genomics Proteomics Bioinformatics (2006) 4.15

Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest (2005) 3.95

Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res (2005) 3.56

Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis (2004) 3.43

ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27

The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature (2012) 3.23

Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet (2012) 3.22

VFDB 2008 release: an enhanced web-based resource for comparative pathogenomics. Nucleic Acids Res (2007) 3.07

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A (2008) 3.03

Mouse transcriptome: neutral evolution of 'non-coding' complementary DNAs. Nature (2004) 3.00

Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res (2004) 2.95

Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation (2013) 2.95

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology (2012) 2.74

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res (2013) 2.71

BGI-RIS: an integrated information resource and comparative analysis workbench for rice genomics. Nucleic Acids Res (2004) 2.69

PGAP: pan-genomes analysis pipeline. Bioinformatics (2011) 2.65

A new role for Nogo as a regulator of vascular remodeling. Nat Med (2004) 2.63

A complete sequence of the T. tengcongensis genome. Genome Res (2002) 2.60

Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab (2007) 2.53

SilkDB: a knowledgebase for silkworm biology and genomics. Nucleic Acids Res (2005) 2.50

A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS One (2007) 2.47

Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis (2009) 2.45

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther (2009) 2.41

The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. Radiother Oncol (2003) 2.41

Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun (2003) 2.35

Pigs in sequence space: a 0.66X coverage pig genome survey based on shotgun sequencing. BMC Genomics (2005) 2.34

The analysis of large-scale gene expression correlated to the phase changes of the migratory locust. Proc Natl Acad Sci U S A (2004) 2.26

The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res (2005) 2.21

Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics (2002) 2.16

Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell (2003) 2.16

Influenza Virus Database (IVDB): an integrated information resource and analysis platform for influenza virus research. Nucleic Acids Res (2006) 2.14

Vertebrate gene predictions and the problem of large genes. Nat Rev Genet (2003) 2.11

On the nature of human housekeeping genes. Trends Genet (2008) 2.06

T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology (2011) 2.05

Compositional gradients in Gramineae genes. Genome Res (2002) 2.04

Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med (2007) 2.04

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer (2009) 2.03

The complete chloroplast genome sequence of date palm (Phoenix dactylifera L.). PLoS One (2010) 1.99

How many human genes can be defined as housekeeping with current expression data? BMC Genomics (2008) 1.97

Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Infect Immun (2005) 1.96

Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun (2004) 1.95

alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma. Pancreas (2010) 1.94

Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology (2012) 1.87

A comparison of rice chloroplast genomes. Plant Physiol (2004) 1.85

KaKs_Calculator 2.0: a toolkit incorporating gamma-series methods and sliding window strategies. Genomics Proteomics Bioinformatics (2010) 1.85

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut (2010) 1.84

CT substitute derived from MRI sequences with ultrashort echo time. Med Phys (2011) 1.84

Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. J Gastroenterol Hepatol (2012) 1.83

Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res (2006) 1.79

Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A (2004) 1.75

ReAS: Recovery of ancestral sequences for transposable elements from the unassembled reads of a whole genome shotgun. PLoS Comput Biol (2005) 1.71

Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res (2011) 1.68

WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res (2008) 1.67

A transcriptomic analysis of superhybrid rice LYP9 and its parents. Proc Natl Acad Sci U S A (2009) 1.67

Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut (2012) 1.67

FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One (2013) 1.65

Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci U S A (2005) 1.64

FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep (2012) 1.63

Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A (2005) 1.62

Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res (2007) 1.62

The rice mitochondrial genomes and their variations. Plant Physiol (2005) 1.59

EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res (2011) 1.58

Origin and evolution of new exons in rodents. Genome Res (2005) 1.57

Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol (2008) 1.56

A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics (2009) 1.56

Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother (2003) 1.56

Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev (2007) 1.55

Evolution of alternative splicing after gene duplication. Genome Res (2005) 1.55

Revisiting the molecular evolutionary history of Shigella spp. J Mol Evol (2006) 1.54

Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother (2005) 1.54

Methods for reverse genetic screening in zebrafish by resequencing and TILLING. Methods (2006) 1.53

DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J Bacteriol (2004) 1.52

The next-generation sequencing technology and application. Protein Cell (2010) 1.52

Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med (2003) 1.52

Prevalence of current pregnancy among US women with and without chronic physical disabilities. Med Care (2013) 1.52

A population threshold for functional polymorphisms. Genome Res (2003) 1.52

Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J Biol Chem (2007) 1.51

Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49

The silkworm (Bombyx mori) microRNAs and their expressions in multiple developmental stages. PLoS One (2008) 1.48

OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One (2008) 1.47

Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis (2003) 1.47

A comparison between ribo-minus RNA-sequencing and polyA-selected RNA-sequencing. Genomics (2010) 1.47

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut (2011) 1.46

Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol (2011) 1.46

Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res (2002) 1.46

Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest (2006) 1.46

Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol (2003) 1.45

ChickVD: a sequence variation database for the chicken genome. Nucleic Acids Res (2005) 1.45

MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis (2010) 1.45

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer (2002) 1.45

Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks. Diabetes Care (2007) 1.45